| Title : Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy - Panigrahy_2024_bioRxiv__ |
| Author(s) : Panigrahy D , Kelly A , Wang W , Yang J , Hwang SH , Gillespie M , Howard I , Bueno-Beti C , Asimaki A , Penna V , Lavine K , Edin M , Zeldin D , Hammock B , Saffitz J |
| Ref : Biorxiv , : , 2024 |
| PubMedID: 38463975 |
| Title : Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts - Edin_2023_J.Biol.Chem__103049 |
| Author(s) : Edin M , Gruzdev A , Bradbury JA , Graves J , Lih F , DeGraff L , Fleming I , Zeldin D |
| Ref : Journal of Biological Chemistry , :103049 , 2023 |
| PubMedID: 36822325 |
| Title : Hepatocyte-specific disruption of soluble epoxide hydrolase attenuates abdominal aortic aneurysm formation: novel role of the liver in aneurysm pathogenesis - Kim_2023_bioRxiv__ |
| Author(s) : Kim D , Horimatsu T , Ogbi M , Goo B , Shi H , Veerapaneni P , Chouhaita R , Moses M , Prasad R , Benson TW , Harb R , Aboud G , Seller H , Haigh S , Fulton DJ , Csanyi G , Huo Y , Long X , Coffey P , Lee R , Guha A , Zeldin D , Hwang SH , Hammock BD , Weintraub NL , Kim HW |
| Ref : Biorxiv , : , 2023 |
| PubMedID: 37503031 |